OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer
Jamie O. Brett, Erica L. Mayer
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 6, pp. 594-610
Closed Access | Times Cited: 9
Jamie O. Brett, Erica L. Mayer
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 6, pp. 594-610
Closed Access | Times Cited: 9
Showing 9 citing articles:
Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study
S W M Lammers, Marissa Meegdes, Ingeborg J. H. Vriens, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103008-103008
Closed Access | Times Cited: 5
S W M Lammers, Marissa Meegdes, Ingeborg J. H. Vriens, et al.
ESMO Open (2024) Vol. 9, Iss. 5, pp. 103008-103008
Closed Access | Times Cited: 5
Immunotherapy boosts responses in hormone receptor-positive breast cancers
Zahi Mitri, Karen A. Gelmon
Nature Medicine (2025)
Closed Access
Zahi Mitri, Karen A. Gelmon
Nature Medicine (2025)
Closed Access
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
Carlo Pescia, Elena Guerini‐Rocco, Giuseppe Viale, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5430-5430
Open Access | Times Cited: 6
Carlo Pescia, Elena Guerini‐Rocco, Giuseppe Viale, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5430-5430
Open Access | Times Cited: 6
Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
Simone Nardin, Tommaso Ruelle, Irene Giannubilo, et al.
Tumori Journal (2023) Vol. 110, Iss. 3, pp. 162-167
Closed Access | Times Cited: 3
Simone Nardin, Tommaso Ruelle, Irene Giannubilo, et al.
Tumori Journal (2023) Vol. 110, Iss. 3, pp. 162-167
Closed Access | Times Cited: 3
Results of Treatment of Patients with Stage I‒Ii Breast Cancer after Subcutaneous/Skin-Preserving Mastectomies with Reconstruction with/without Radiation Therapy
E.A. Rasskazova Rasskazova, A.D. Zikiryakhodzhaev
Medical Radiology and radiation safety (2024) Vol. 69, Iss. 4, pp. 81-87
Open Access
E.A. Rasskazova Rasskazova, A.D. Zikiryakhodzhaev
Medical Radiology and radiation safety (2024) Vol. 69, Iss. 4, pp. 81-87
Open Access
Oncological outcomes of stage I–II breast cancer treatment after subcutaneous/skin-sparing mastectomies with reconstruction
Е. А. Рассказова, А. D. Zikiryakhodzhaev
MD-Onco (2024) Vol. 4, Iss. 3, pp. 37-44
Closed Access
Е. А. Рассказова, А. D. Zikiryakhodzhaev
MD-Onco (2024) Vol. 4, Iss. 3, pp. 37-44
Closed Access
FloraStilbene: immunotherapy adjuvant for breast cancer
Famela Ramos, Santosh Kesari, George Delgado, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 45-53
Open Access
Famela Ramos, Santosh Kesari, George Delgado, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 45-53
Open Access
Investigation into the Quantitative Structure‐Biotoxicity Relationship of Antibiotics and their Estrogenic Receptor Disruption Effects
Wenwu Zhu, Shuangkou Chen, Yu Wang, et al.
Chemistry & Biodiversity (2024)
Closed Access
Wenwu Zhu, Shuangkou Chen, Yu Wang, et al.
Chemistry & Biodiversity (2024)
Closed Access
Hormone Therapy and Oral Medications in Breast Cancer
Çiğdem Dinçkal, Murat Akyol
(2024), pp. 83-95
Closed Access
Çiğdem Dinçkal, Murat Akyol
(2024), pp. 83-95
Closed Access
